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INTRODUCTION
A stress response consisting of increased levels of cortisol and catecholamines in 
the  first  weeks  after  acute  stroke  has  been  known since  the  1950s1-4,  and  a  failure  of 
dexamethasone suppression of cortisol levels indicated a dysregulation of the hypothalamic 
pituitary adrenal (HPA) system1.The cortisol response has been identified in both cerebral 
infarction and intracerebralhaemorrhage1-4. High s-cortisol levels have been related to poor 
outcome 2, 6. It is, however, not known whether this adrenal glucocorticoid stress response is 
beneficial  or  harmful  to  the  damaged  brain.   
The cortisol  response is  related positively to blood glucose  8 a  parameter  that 
increases after severe stroke 6-9 possibly resulting from the stress response. It has been reported 
that cortisol correlated positively to white blood cell count, fibrinogen, and other markers of 
the inflammatory response after stroke10 as well as IL-611, and it was suggested that cytokines 
modulate the cortisol response after acute stroke11 by stimulating the HPA axis leading to 
increased levels of cortisol in the periphery12. Some researchers suggested that the association 
between high stress hormone levels and less favourable outcome could be related to cardiac 
abnormalities resulting from the increased levels of stress-hormones2,  3. In one study, the 
degree of sympathetic activation was associated with the extent of the damage to the insula, 
which is assumed to be involved in the regulation of the autonomic nervous system13. Insular 
damage in experimental stroke has also been shown to result in an increase in the circulating 
levels  of  catecholamines  suggesting  this  as  a  mechanism for  the  cardiac  complications 
associated  with  stroke14.  
It has also been observed that the normal circadian rhythm of cortisol is suspended during 
acute  stroke  as  equal  levels  of  cortisol  were  found  round  the  clock15.  
Whether  the  stress  response  is  just  an  epiphenomenon  to  stroke  severity  or 
independently contributes to prognosis remains uncertain. Furthermore, the stress response 
has not yet been put in perspective by evaluation in the context of parameters generally 
assumed  to  be  of  importance  in  acute  stroke.  
                                             
      AIM
1. The  aim  of  the  study  was  to  investigate  if  a  single  serum  cortisol 
determination related to stroke severity. 
2. If cortisol is related to paraclinical parameters in acute stroke in order to 
gain knowledge of the relations between cortisol and other paraclinical 
variables of known relevance to stroke.
REVIEW OF LITERATURE
A  stroke  (previously  known as  a  cerebrovascular  accident)  is  rapidly  developing 
clinical symptoms and/or signs of focal, and at times global (applied to patients in deep coma 
and to those with subarachnoid haemorrhage) loss of brain function, with symptoms lasting 
more than 24 hours or leading to death, with no apparent cause other than that of vascular 
origin17. There is a wide range of severity, from recovery in a few days, through persistent 
disability, to death.
A  transient ischaemic attack  (TIA) is an acute loss of focal  brain or monocular 
function with symptoms lasting less than I  24 hours and which is thought to be due to 
inadequate cerebral or ocular blood supply as a result of arterial thrombosis, embolism, or 
low flow, associated with arterial, cardiac, or haematological disease18. About 80 per cent 
of all strokes are ischaemic, 10 per cent are due to primary intracerebral haemorrhage, about 5 
per cent are due to subarachnoid haemorrhage.
 
After coronary heart disease and all cancers, stroke is the third most common cause 
of death in the world, causing-about  4 million deaths in 1990, three-quarters of them in 
developing countries19. A typical estimate of stroke prevalence is about 5/1000 population, 
but clearly the exact figure depends on the population age and sex structure, and becomes 
about 50/1000 in men and 25/1000 in women aged 65-7420. 
     South Asian populations  have a high prevalence of  coronary heart disease, 
central  obesity  (i.e.  high  waist-to-hip  ratio),  insulin  resistance,  non-insulin-dependent 
diabetes, and hypertension21, and a high stroke mortality, but there is no good information 
on  incidence22.  This  seems  to  be  due  partly  to  genetic  susceptibility  (high  serum 
lipoprotein  (a)  levels)  in  these  people,  potentiated  by  dietary-  and  lifestyle-induced 
changes in lipid levels 23.  
Risk factors for ischaemic stroke
• Age
• Male sex
• Increasing blood pressure 
• Cigarette smoking 
• Blood lipids
• Diabetes mellitus 
• Increasing plasma fibrinogen 
• Raised factor VII coagulant activity 
• Raised tissue plasminogen activator antigen 
• Low blood fibrinolytic activity
• Raised von Willebrand factor
• Raised haematocrlt
• Atrial fibrillation
• Sex hormones
• Excess alcohol consumption
• Obesity and diet
• Physical Inactivity
• Raised white blood cell count
• Recent Infection
• Hyperhomocysteinaemia
• Snoring
• Corneal arcus
• Psychological factors
• Vasectomy
• Low serum albumin
• Diagonal earlobe crease
• Impaired ventilatory function
• Family history of stroke
• Social deprivation
• Evidence of pre-existing vascular disease
• Myocardial  infarction/angina
• Cardiac failure
• Left ventricular hypertrophy
• Peripheral vascular disease
• Cervical arterial bruit and stenosis
• Transient Ischaemic attacks
Age 
Age  is  the  strongest  risk  factor  for  ischaemic  stroke,  primary  intracerebral 
hemorrhage, and subarachnoid hemorrhage24.
   Sex
There is a small excess of males, which is most prominent in middle to old age, disappearing 
in the very elderly and probably absent in the young. 
Blood pressure
In healthy populations, in both sexes and allowing for the association with age, increasing 
blood pressure is strongly associated with subsequent stroke risk, and probably with all the main 
pathological types24. Although most of the information comes from consideration of the diastolic 
blood pressure, the relationship with systolic blood pressure is similar and possibly stronger, and 
evens 'isolated’ systolic hypertension is associated with increased risk25.  
The association between increasing blood pressure  and stroke is less in the elderly than in 
middle age. What is not quite so clear is whether hypertension is still a risk factor in the very elderly, 
where stroke may be associated with low pressures, perhaps because low pressures are a reflection 
of pre-existing cardiovascular and other disease  26.  Hypertension probably increases stroke risk by 
increasing the  extent and severity of atheroma27  and the prevalence of small vessel disease in the 
perforating arteries within the brain.
Cigarette smoking  
Cigarette smoking has been better accepted as a risk factor for coronary heart disease than stroke. 
However,  there is no doubt of an association with stroke, there is a  dose-response relationship, 
males and females are equally affected, the association seems to become weaker in the elderly, and 
there is perhaps an association with passive smoking28. Although smoking is a strong risk factor for 
subarachnoid  haemorrhage  and  for  ischaemic  stroke  there  appears  to  be  less  association  with 
primary intracerebral haemorrhage28, 29. Ex-cigarette smokers have a sustained excess risk of stroke for 
some years 
 
 Blood lipids 
    Any relationship between blood lipids and stroke is much weaken, if it exists at 
all30, 31, although perhaps Increased serum lipoprotein (a) is predictive, Some attempts to 
relate atheroma in the extra and intracranial circulation to blood lipid concentrations have 
suggested an association.
             
Diabetes mellitus
Diabetes mellitus has long been recognised as a risk factor for vascular disease and 
about doubles the risk of stroke compared with non-diabetics, probably independently of 
any association with other risk factors such as hypertension.32, 33    
 Pathophysiology of acute cerebral ischaemia
The brain normally derives its energy from the oxidative  metabolism of glucose. 
Because there are negligible stores of  glucose in the brain, when CBF falls and the brain 
becomes  ischaemic,  a  series  of  neurophysiological  and  functional  changes,  which are 
dependent on the oxidative metabolism of  glucose to provide energy in the form of ATP, 
occur at various thresholds of flow before cell death. Different mechanisms are responsible 
for  reversible  loss  of  cellular  function,  and  for  irreversible  cell  death,  and  there  are 
differences between the mechanisms that cause death of neurons, glia, and endothelial cells, 
and perhaps between white matter and grey matter34, 35
 Cerebral ischaemia causes not only reversible and then irreversible loss of brain 
function,  but also  cerebral oedema36 Ischaemic oedema it partly  'cytotoxic’  and partly 
'vasogenic'. Cytotoxic oedema starts within minutes of stroke onset, and affects the grey 
more than the white matter, with damaged cell membranes allowing intracellular water 
to accumulate. 
Vasogenic oedema, which starts rather later,  within hours of stroke onset affects 
the white matter more than the grey  the  damaged  blood-brain  barrier allowing plasma 
constituents  to  enter  the  extracellular  space,  Ischaemic  cerebral  oedema  when  its 
maximum in 2-4 days and then subsides over a week or two.
         Hyperglycemia is   associated with a poor outcome after stroke, either because 
the consequences of ischaemia are exacerbated in the presence of high blood glucose 
concentrations,  perhaps  mediated  by  excess  lactate  production37,  or  because 
hyperglycemia reflects the stress response, and so the severity of the  initial stroke38,  39. 
Clearly, trials of glucose lowering need to be done to sort this out. 
Fever is associated with a worse outcome and hypothermia with a better outcome 
in stroke but, like blood sugar, it  is not clear whether this association represents a causal 
relationship, and therefore whether any intervention would be worthwhile. Dehydration, 
increasing  haematocrit,  and  raised  whole  blood  viscosity  are  further  potential 
exacerbating factors.
The causes of stroke
Cerebral ischaemia and infarction are usually caused by sudden occlusion of an 
artery supplying the brain or, less often, by low flow distal to an already occluded or 
highly stenosed artery. Occlusion or stenosis can be the result of disease of the arterial 
wall;  embolism  from  the  heart;  haematological  disorders;  and  various  rare,  but 
sometimes  treatable,  conditions  which  are  proportionately  more  common  in  young 
stroke patients (where  degenerative arterial disease is unusual) but which can still be a 
cause of stroke in the elderly.  
Causes of ischaemia and infarction
  
• Arterial wall disorders
o Atheroembolism
o Intracranial small vessel disease
o Trauma
o Dissection
o Fibromuscular dysplasia
o Congenital arterial anomalies
o Moyamoya syndrome
o Embolism from arterial aneurysms
o Leukoaraiosis
o Irradiation
o Infection
• Embolism from the heart 
• Haematological disorders 
• Miscellaneous conditions 
• Pregnancy/puerperium
• Oral contraceptives and other female sex hormones 
• Drug  abuse
• Cancer
• Perioperative
• Migraine
• Inflammatory bowel disease
• Homocystinaemia
• Fabry's disease
• Mitochondrial cytopathy
• Hypoglycaemia
• Fibrocartilaginous embolism
• Snake bite
• Fat embolism
• Epidermal naevus syndrome
• Susac's syndrome
• Nephrotic syndrome 
Atheroma seems to be an almost inevitable accompaniment of ageing, at least in 
developed  countries.  It  is  by  far  the  most  common  arterial  disorder  and,  when 
complicated by thrombotic or embolism, Is the most frequent, but by no means only, 
cause of cerebral ischaemia and infarction.
 
The approximate relative frequency of the main causes of ischaemic stroke and TIA  
    
Atherothrombosis  affecting  large  and 
medium-sized  arteries  between  the 
heart and the brain 
50%
Intracranial small vessel disease  25%
Embolism from the heart 20%
Rare disorders 5%
Distribution of atheroma
Atheroma mainly affects large  and medium-sized arteries at  places of arterial 
branching, tortuosity , and confluence40. These are sites of haemodynamic sheer stress 
and  thus  endothelial  trauma;  boundary  layer  separation,  blood  stagnation,  and  the 
accumulation  of  platelets;  and  of  turbulence,  all  of  which  are  likely  to  promote 
thrombosis41 .Atheroma  starts  in  childhood,  it  is  thought  in  response  to  endothelial 
injury42. The plaques are complicated by platelet adhesion, activation, and aggregation, 
which inmates blood coagulation and subsequent thrombosis.
Causes of dissection of the extra- and Intracranial arteries 
 Traumatic 
 Penetrating injury 
 Non-penetrating Injury
 Spontaneous 
 Fibromuscular dysplasia 
 Cystic medial necrosis 
 Marfan's syndrome 
 Ehlers-Danlos syndrome 
 Pseudoxanthoma elasticum 
 Inflammatory arterial disease
 Infective arterial disease (e.g. syphilis) 
 
Spontaneous intracranial haemorrhage
Spontaneous  intracranial  haemorrhage  occurs  within  the  brain  (primary 
intracerebral  haemorrhage),  into  the  subarachnoid  space  (subarachnoid  haemorrhage), 
sometimes into the ventricles (intraventricular haemorrhage), and rarely into the subdural 
space  (subdural  haemorrhage).  The  exact  site  of  origin  may  not  necessarily  be 
immediately obvious because,  for  example,  a  saccular aneurysm can rupture into the 
brain as well as into the subarachnoid space, or disruption of a small perforating artery 
can cause intraventricular haemorrhage as well as a basal ganglia haematoma. Even at 
post-mortem, there may be uncertainty because the source of the haemorrhage may well 
have been destroyed, particularly if small (e.g. a tiny intracranial vascular malformation). 
The causes of intracranial haemorrhage are much the same, whatever the primary site of 
the bleeding, although their relative frequency varies somewhat with the site.
Causes of spontaneous Intracranial haemorrhage.
o Hypertension 
o Aneurysms
 Saccular 
 Atheromatous 
 Mycotic 
 Myxomatous 
 Dissecting 
o Cerebral amyloid angiopathy 
o Intracranial vascular malformations 
 Arteriovenous (cerebral, dural)
 Venous
 Cavernous 
 Telangiectasis
o Haemostatic failure
 Haemophilia and other coagulation disorders 
 Thrombocytopenia
 Thrombotic thrombocytopenic purpura 
 Anticoagulation 
 Therapeutic thrombolysis 
 Antiplatelet drugs 
 Polycythaemia rubra vera 
 Essential thrombocythaemia 
 Paraproteinaemias
 Disseminated intravascular coagulation 
 Renal failure 
 Liver failure 
 Snake bite
o Inflammatory vascular disease 
o Haemorrhagic transformation of cerebral infarction
o Intracranial venous thrombosis 
o Sickle-cell disease/trait 
o Moyamoya syndrome 
o Carotid endarterectomy 
o Posterior fossa and other intracranial surgery
o Delayed post-traumatic 'spat-apoplexie'
o Alcoholic binge 
o Wernicke's encephalopathy
o Vascular tumours 
o Melanoma 
o Choriocarcinoma 
o Malignant astrocytoma 
o Oligodendroglioma
o Medullobiastoma 
o Haemangioblastoma 
o Choroid plexus papilloma 
o Hypernephroma 
o Endometrial carcinoma 
o Bronchogenic carcinoma
o Drug abuse 
o Infections  
 Herpes simplex 
 Leptospirosis 
 Anthrax 
 Chronic meningitis
 Scorpion bite
o Silastic dural substitute 
Primary Intracerebral haemorrhage
Primary  intracerebral  haemorrhage  (PICH)  is  somewhat  more
frequent  than  subarachnoid  haemorrhage,  the  incidence
increases  with  age.  It  is  most  commonly  due  to  intracranial  small  vessel  disease 
associated  with  hypertension,  cerebral  amyloid  angiopathy,  and  intracranial  vascular 
malformations, but there is usually a combination of different factors operating in any 
one individual, e.g. hypertension and cerebral amyloid angiopathy, therapeutic throm-
bolysis  and  a  vascular  malformation,  etc.43Less  common  causes  include  saccular 
aneurysms;  haemostatic  defects,  particularly  induced by anticoagulation44,  therapeutic 
thrombolysis, perhaps with cerebral amyloid angiopathy, and possibly antiplatelet drugs; 
cerebral vasculitis and drug abuse. 
The site of PICH, shown on CT, provides some clue to the cause; 'hypertensive' 
haemorrhages tend to occur slightly more in the basal ganglia, thalamus, and pons, while 
lobar haemorrhages (i.e. superficial in cerebrum) tend to be somewhat more often due to 
cerebral  amyloid  angiopathy,  vascular  malformations,  and  haemostatic  failure. 
Occasionally PICHs occur in different parts of the brain simultaneously, or over a short 
period of time. Rarely, PICH is familial.
Spontaneous subarachnoid haemorrhage
The incidence of spontaneous subarachnoid haemorrhage (SAH) increases with 
age  and is  about  5-10/100 000 population/annum,  being somewhat  more  frequent  in 
women than men. A ruptured saccular aneurysm is by far the most common cause45. 
Some SAHs are due to bleeding from an intracranial vascular malformation, a few are 
due to rarities, and depending on the intensity of investigation in about 15 per cent no 
cause can be identified in life  46.Primary intraventricular haemorrhage is very unusual, 
except in premature babies. In adults, a cause is not always found. Some may be due to a 
vascular malformation in the ventricular wall47.  The clinical features are so similar to 
SAH that it can only be differentiated on CT, or at post-mortem.
Subdural  haemorrhage  is  more  often  traumatic,  or  due  to  ventricular 
decompression for hydrocephalus, than spontaneous (but remembering that trauma can 
so easily be ignored or forgotten). Rupture of a vascular malformation in the dura or of a 
very peripheral aneurysm (mycotic much more likely than saccular), a haemostatic defect 
(particularly  therapeutic  anticoagulation),  or  a  peripheral  cerebral  tumour  can  be 
responsible. It is also a very rare complication of lumbar puncture.
 
Transient ischaemic attacks
About 15 per cent of first stroke patients have had earlier TIAs, but only about half 
of  them  consult  a  doctor.  Therefore,  the  incidence  of  TIAs  presenting  to  medical 
attention (about 0.5 per 1000 population per annum) must be an underestimate of the real 
situation18, 48. By definition, the symptoms last less than 24 hours, but a few patients have 
residual neurological signs of no functional significance, e.g. reflex asymmetry. About 25 
per  cent  have focal  hypodensity  on CT,  relevant  to  the symptoms in about half  and 
therefore perhaps representing recent infarction49. 
An even higher proportion has focal lesions on MRI50.  However, the diagnosis 
depends  not  on either neurological signs or imaging but essentially on the nature and 
duration of the symptoms in the right 'vascular'  milieu (elderly, vascular risk factors, 
absent  pulses,  and  bruits,  etc.).  Fortunately,  in  general,  there  is  less  inter  observer 
disagreement about symptoms, which are remembered, than signs which are likely to 
attenuate  and  disappear51.  The  main  use  of  brain  imaging  is  to  rule  out  the  very 
occasional structural lesion causing 'transient focal neurological attacks'.
Causes of transient focal neurological attacks 
o Focal cerebral ischaemia (i.e. TIA) 
o Migraine with aura
o Partial epileptic seizures
o Structural intracranial lesions 
o Tumour
o Chronic subdural haematoma 
o Vascular malformation 
o Giant aneurysm
o Multiple sclerosis
o Labyrinthine disorders
o Peripheral nerve or root lesion 
o Metabolic
 Hypoglycaemia
 Hyperglycaemia
 Hypercalcaemia
 Hyponatremia
o Psychological
Symptoms of T I A
• Unilateral weakness, heaviness, or clumsiness
• Unilateral sensory symptoms
• Dysarthria
• Transient monocular blindness
• Dysphasia
• Unsteadiness/ataxia
• Bilateral simultaneous blindness
• Vertigo
• Homonymous hemianopia
• Diplopia
• Bilateral motor loss
• Dysphagia
• Crossed sensory and motor loss 
Clinical features.
The diagnosis of stroke is straightforward if there is a clear history of focal brain 
dysfunction which started suddenly, or was first noticed on waking, particularly if  the 
patient has not had a previous stroke, is over the age of 50, and has vascular risk factors 
or disorders. There may be some progression over the first few minutes or hours, but 
usually the deficit stabilizes by 12-24 hours and, if the patient survives, recovery starts 
within a few days in most cases. The severity ranges from a trivial deficit, which is gone 
in a day, through a persistent deficit with or without disability, to death within hours of 
onset.
 
If the history is clear-cut, the chance of a CT or MRI brain scan showing anything 
other  than  an  infarct  or  haemorrhage  (or  being  normal  if  done  early  in  the  case  of 
infarction or the lesion is very small) is under five per cent52. If there is doubt about the 
speed  of  onset  of  a  focal  deficit,  then  the  diagnosis  is  rather  more  likely  to  be  an 
intracranial mass lesion, such as a tumour or chronic subdural haematoma. If the onset 
was clearly sudden, but there was no obvious focal deficit, then brain imaging may show 
a thalamic or cerebellar infarct or haemorrhage. Clinical clues to an intracranial tumour 
are recent headaches, seizures, papilledema, a worsening deficit over days or weeks, and 
any suggestion of  a  primary tumour  out  with the brain.  Clues to  a  chronic  subdural 
haematoma are head injury in the previous few weeks; more drowsiness, confusion and 
headache  than anticipated  from the severity  of  the  neurological  deficit;  a  fluctuating 
course; and a patient on anticoagulants. 
Other diagnoses are usually but not necessarily obvious: multiple sclerosis (young 
age); peripheral nerve or root lesion (clinical signs); post-seizure hemiparesis (history); 
metabolic encephalopathy (global rather than focal neurological features); somatization 
and  hysteria  (young  age,  signs);  encephalitis  (fever,  clinical  symptoms  and  signs, 
diffusely abnormal EEG); and intracranial abscess (fever and predisposing cause such as 
sinusitis, congenital heart lesion, etc.)53. Occasionally, head injury causing intracerebral 
haemorrhage can be missed if  the patient  is  amnesic for  the injury itself  and has an 
unmarked scalp; while ischaemic stroke shortly after an obvious head injury may be due 
to neck artery dissection. 
Haemorrhagic strokes causing a fall and so head injury can be equally confusing if 
the CT scan shows ‘primary intracerebral haemorrhage' or 'subarachnoid haemorrhage' 
and the circumstances at  the onset  are unclear54.  If  there are persisting signs from a 
previous stroke, and the patient then falls ill for some other reason such as an infection, 
or has an epileptic seizure, the old signs may appear to worsen and so mimic stroke 
recurrence. 
                                                                                                         
Determining  the  site  of  the  lesion  depends  on  classical 
clinicoanatomical  correlation55.  A  simple  system,  which  does  not  require  great 
neurological skill, divides stroke patients first into four main clinical syndromes: total 
anterior  circulation  syndrome (TACS),  partial  anterior  circulation  syndrome (PACS), 
lacunar syndrome (LACS), and posterior circulation syndrome (POCS). Occasionally one 
has to put the patient in an uncertain category. This division depends entirely and only on 
the symptoms and signs, which are accessible to everyone, irrespective of the availability 
or standard of any technology. 
Next,  based  on brain  CT or  perhaps  MRI,  patients  with  primary  intracerebral 
haemorrhage  are  separated  off.  The  rest,  where  the  scan  is  either  normal  or  shows 
infarction in a relevant area, can then be divided into: total anterior circulation infarct, 
about  15  per  cent  of  the  total  in  community-based  studies  (TACI);  partial  anterior 
circulation infarct, 35 per cent (PACI); lacunar infarct, 25 per cent (LACI); and posterior 
circulation  infarct,  25  per  cent  (POCI)56.These  categories  provide  some  prognostic 
information for  survival,  residual  disability,  and recurrence,  and an indication of  the 
cause of the stroke57 
Total anterior circulation syndrome (TACS) 
A large haematoma in one cerebral hemisphere, or an infarct large enough to affect 
the cortex, basal ganglia, and internal capsule, causes a characteristic clinical syndrome 
of contralateral hemiparesis, with or without a sensory deficit, involving the whole of at 
least two of the three body areas (face, upper limb, lower limb), a homonymous visual 
field  defect,  and  new  higher  cerebral  or  'cortical'  dysfunction  (dysphasia,  neglect, 
visuospatial problems, etc., depending on cerebral dominance). Total anterior circulation 
infarcts.  (TACIs)  ate  usually  due  to  acute  occlusion  of  the  internal  carotid  artery 
(normally atherothrombotic), or embolic occlusion of the proximal middle cerebral artery 
from a cardiac or proximal arterial source58. 
Partial anterior circulation syndrome (PACS)
 A lobar  haemorrhage,  or  a  cortical  infarct,  causes  a  more  restricted  clinical 
syndrome consisting of only two of the three components of the total anterior circulation 
syndrome;  or  just  isolated  higher  cortical  dysfunction  such  as  dysphasia;  or  a  pre-
dominantly proprioceptive deficit in one limb; or a motor/ sensory deficit restricted to 
one body area or part of one body area59. If the 'cortical' signs are rather subtle (dressing 
apraxia, neglect, dysphasia mistaken for dysarthria, etc.),the patient may be misclassified 
as 'lacunar'.
Partial anterior circulation or cortical infarcts (PACIs) are caused by occlusion of a 
branch of the middle cerebral artery, or rarely the trunk of the anterior cerebral artery, 
usually as a consequence of embolism from the heart or proximal atherothrombosis, in 
the same ways as TACIs. Anterior cerebral artery infarcts cause contralateral weakness, 
predominantly of the lower limb, perhaps with some cortical sensory loss, and aphasia if 
in the dominant hemisphere.
Lacunar syndrome (LACS)
Lacunar syndromes are defined clinically and are highly predictive of small, deep 
lesions affecting the motor and/or sensory pathways, i.e. in the corona radiata, internal 
capsule, thalamus, cerebral peduncle, and pons59, 60. 
The four main lacunar syndromes are most reliably defined if  there has been no 
previous stroke and if the patients are examined at the time of their maximal deficit
1pure motor stroke
2 pure sensory stroke
3 sensorimotar stroke
4 ataxic hemiparesis
Posterior circulation syndrome (POCS)
Brainstem, cerebellar, thalamic, or occipital lobe signs normally indicate infarction 
in  the  distribution  of  the  vertebrobasilar  (i.e.  posterior)  circulation61,  or  a  localized 
haemorrhage. A combination of brainstem and occipital lobe signs is highly suggestive of 
infarction due to thromboembolism within the basilar and posterior cerebral artery (PCA) 
territories. Occasionally, proximal PCA occlusion causes enough temporal, thalamic and 
perhaps midbrain infarction to cause some contralateral hemiparesis and sensory loss.  A 
marked  cognitive  deficit  such  as  aphasia,  as  well  as  the  expected  homonymous 
hemianopia, and so be confused with occlusion of the middle cerebral artery or one of its 
branches62;  this  is  the  so-called 'walking total  anterior  circulation  syndrome (TACS)' 
because although it fulfils the definition of a TACS, the motor loss is mild. The causes of 
infarction in the vertebrobasilar territory are rather heterogeneous and, in individual.
Investigations of stroke
Apart from routine investigations 
• Full blood count
• ESR
• Electrolytes
• Urea
• Plasma glucose
• Plasma cholesterol
• Urine analysis
• Electrocardiogram
C T Brain.
When  it  is  essential  to  exclude  PICH,  there  is  no  alternative  to  a  CT  scan, 
preferably within hours of stroke onset before any haematoma has vanished.
Ischaemic stroke, the CT scan is normal immediately after onset, and if the lesion 
is small (less than about 0.5 cm in diameter), or in the posterior fossa, the scan may 
remain normal. With larger infarcts, a diffuse low-density area begins to appear, due to 
increasing brain water content, within a few hours. This may be accompanied by subtle 
effacement of sulci and loss of the normal grey-white matter differentiation, loss of the 
insular ribbon, loss of outline of the lentiform nucleus, and compression of the adjacent 
ventricle63. 
When the lesion is large, more obvious infarct swelling, brain shift, and herniation 
may  be  seen  a  few  days  after  onset.  In  addition,  CT  can  show  haemorrhagic 
transformation, either asymptomatic or symptomatic, and although this tends to occur a 
few  days  after  stroke  onset  in  large  infarcts,  it  can  happen  within  hours  and  the 
haemorrhagic area can look very like a primary haemorrhage  64. MRI is more sensitive 
but less specific than C T. 
Primary intracerebral  haemorrhage  (PICH) appears  at  once on CT as a  well-
demarcated high-density round or oval area, with or without rupture into the ventricles or 
on to the surface of the brain. Lesions as small as 0.5cm in diameter can be picked up. 
Mixed-density haemorrhages, suggesting blood of different ages, is rather characteristic 
of amyloid angiopathy, and a blood-fluid level suggests a haemostatic defect of some 
sort65.
MRI is less; available than CT and patients have to lie still for longer, which for 
acute stroke makes CT the preferred immediate imaging technique, particularly since it 
displays intracerebral haemorrhage more reliably66. MRI is not necessarily superior to CT 
in detecting the very earliest signs of cerebral infarction 67.
Cortisol
Cortisol  is  the  predominant  corticosteroid  secreted  from the  adrenal  cortex  in 
humans. In a healthy, unstressed person, cortisol is secreted according to a diurnal pattern 
under  the  influence  of  corticotropin  released  from the  pituitary  gland.  Corticotropin 
secretion,  in  turn,  is  under  the  influence  of  hypothalamic  corticotropin  -  releasing 
hormone  and both hormones are subject to negative feedback control by cortisol itself. 
Circulating  cortisol  is  bound  to  corticosteroid    binding  globulin,  with  less  than  10 
percent in the free, bioavailable form.
 With severe infection, trauma, burns, illness, or surgery, there is an increase in 
cortisol  production by as much as a factor,  of six that is  roughly proportional to the 
severity of the illness68. Diurnal variation in cortisol secretion is also lost. These effects 
are due to increased production of cortisol secretion is also lost. These effects are due to 
increased  production  of  corticotropin  -  releasing  hormone  and  corticotropin  and  a 
reduction  in  negative  feedback  from  cortisol69.  Stimulation  of  the  hypothalamic  - 
pituitary  -  adrenal  axis  in  this  context  is  caused  by  elevated  levels  of  circulating 
cytokines, among other factors70.
Adrenal responsiveness to exogenous corticotropin is normally maintained during 
acute illness71. In addition, during critical illness, levels of corticosteroid binding globulin 
decrease rapidly72, leading to increase at sites of inflammation owing to the cleavage of 
corticosteroid - binding globulin by neutrophil elastate, an effect that liberates cortisol75. 
In addition to having systemic actions, inflammatory metabolism10 and can increase the 
affinity of glucocorticoid receptors for cortisol11. These changes in cortisol action appear 
to be important adaptive mechanisms regulating the inflammatory response70.
During severe illness, many factors can impair the normal corticosteroid response. 
These  factors  include  preexisting  conditions  affecting  the  hypothalamic  -  pituitary  - 
adrenal axis76, but corticosteroid insufficiency can also occur during the course of acute 
illness.  Responses involving corticotropin releasing hormone and corticotropin can be 
impaired by head injury, central nervous system depressants, or pituitary infarction77. 
Adrenal  cortisol  synthesis  can  be  impaired  by  multiple  meachanisms71,76.  The 
anesthetic agent etomidate and the antifungal agent ketoconazole inhibit the activity of 
enzymes involved in cortisol synthesis78. Adrenal hemorrhage can occur in sick patients, 
especially those with septicemia and underlying coagulopathy, and adrenal insufficiency 
can occur when there  is  extensive destruction of  adrenal  tissue caused by tumors or 
infection.  The high levels of inflammatory cytokines in patients with sepsis can also 
directly inhibit adrenal cortisol synthesis79.
Ischaemic stroke is a stress factor triggering a complex defensive reaction called 
"alarm reaction" by Selye. Stress gives rise to liberation of catecholamines, dopamine 
beta-hydroxylase in the blood, cerebro-spinal fluid and urine. Patients with ischaemic 
stroke  were  found  to  have  increased  adrenaline,  noradrenaline,  and  3-metoxy-4-
hydroxymandelic acid level in urine and increased cortisol level in blood serum. Patients, 
especially those with severe ischaemic stroke have increased concentrations of glucose 
metabolites in blood and cerebro-spinal fluid: pyruvate acid, lactic acid, acetylacetic acid 
and hydroxybutyric acid.
In acute illness, cortisol secretion increases whereas that of the adrenal androgens, 
and dehydroepiandrosterone sulfate declines. The period following ischemic stroke can 
be considered as a reaction to a stressful event. Changes in cortisol secretion are one of 
the indicators of stress reaction
Increased levels of glucocorticoids (GCs) released from the adrenal cortex during 
stress have negative effects on many organ systems and may impair the immune system, 
myocardial function and affect carbohydrate, protein and fat metabolism. In vitro and in 
vivo studies  have  demonstrated  neurotoxic  effects  of  GCs,  including exacerbation  of 
hypoxic  injury  to  neurones80.  Experimental  ischaemic  injury  to  neurones  is  thus 
potentiated by high physiological levels of GCs and attenuated after adrenalectomy81-83. 
Prolonged sustained exposure to GCs may also influence cognition and mood84. 
Central for these effects is the hippocampal formation, important for mood and cognition 
and with a high density of corticosteroid receptors85, 86. However, adrenalectomy per se 
can also induce neuronal  injury  and adequate  circulating GC levels  are  essential  for 
maintaining body homeostasis87.
Acute stroke is associated with increased activity in the hypothalamic-pituitary-
adrenal axis resulting in increased cortisol production and elevated circulating cortisol 
level88-90.  Previous  research  have  shown  that  excessive  cortisol  levels  after  stroke  is 
associated with cognitive dysfunction89-91,  severity of hemiparesis89,92 and may predict 
stroke outcome and the later development of depression93 . In contrast, low circulating 
cortisol levels have been associated with poor outcome after burns and septicemia94-97, 
stressing the importance of cortisol for the maintenance of vital functions. 
During the first few days after stroke, there is an initial rise of ACTH and cortisol 
but  a subsequent,  rapid decline of ACTH with a persisting increase of cortisol.  This 
dissociation  between  ACTH  and  cortisol  is  most  likely  due  to  a  cortisol-induced 
depression of ACTH levels combined with an increased responsiveness at the adrenal 
levels88, 90.
Another factor likely to contribute to the altered adrenal steroid production is an 
increased cytokine drive in stroke patients98, i.e. release of interleukin (IL)-1, IL-6 and 
tumour necrosis factor alpha, which act on several levels of the HPA axis99-100. Thus, an 
increased cytokine drive may be partially responsible for the observed cortisol/adrenal 
dissociation.
Increased cortisol levels may induce cognitive dysfunction101 and in experimental 
studies GCs in conjunction with ischaemia exert a toxic effect on neurones, especially 
those  in  the  hippocampus81,  102,  where  it  can  induce  hippocampal  pyramidal  neurone 
degeneration. Hippocampal stimulation during surgery in man is known to inhibit the 
cortisol  axis,  and  the  hippocampus  is  suggested  to  be  important  for  the  feedback 
regulation  for  the  cortisol  axis84,  103.  Hippocampal  dysfunction  may  thus  lead  to 
hypercortisolism that,  in  turn,  may aggravate  existing damage,  resulting in  a  vicious 
circle. 
Even  minor  doses  of  exogenously  administered  cortisol  cause  a  decreased 
cognitive performance101,  suggesting that the increases seen in the present report may 
contribute  to  the  observed  disorientation.  Furthermore,  disorientation  may  be  an 
important contributor to, and predictor of, the outcome in acute stroke104, 105.
                           
MATERIALS AND METHODS
   Patients 
The study included 60 patients with acute stroke in the study within 24 h of stroke 
onset after informed consent. The patients were recruited from medical wards in 
government general hospital. Of them, 13 patients we excluded as per exclusion criteria. 
The remaining 47 patients were selected for the study. 
Exclusion criteria
 1. Pregnancy 
2. Liver disease 
3. Age <18
4. Patients who are taking following drugs  
       a.phenytoin 
       b. rifampicin 
       c. ketaconazole
       d. steroids 
Methodology  
Blood pressure, pulse rate, body temperature, and Scandinavian Stroke Scale (SSS) were 
recorded in all patients at  their arrival in hospital. Diagnosis of cerebral infarction or 
intracerebral haemorrhage was based on clinical findings and CT-scan in all patients. 
Blood samples are  taken  for  total  count,  blood  sugar,  and  serum  cortisol.  
Single-measurement serum cortisol was chosen as a previous study has shown that a 
circadian rhythm cannot be demonstrated in acute stroke(15).
Scandinavian stroke Scale
(Scandinavian Stroke Study Group, 1985)
Consciousness:  fully  conscious  -  6,  somnolent,  can  be  awaked  to  full 
consciousness - 4, reacts to verbal command, but is not fully conscious - 2, coma - 0; 
Orientation: correct for time, place and person - 6, two of these - 4, one of these - 
2, completely disorientated - 0; 
Speech: no aphasia - 10, impairment of comprehension or expression disability - 
6, more than yes/no, but not longer sentences - 3, only yes/no or less - 0; 
Eye movement: no gaze palsy - 4, gaze palsy present - 2, forced lateral gaze - 0; 
Facial palsy: none/dubious - 2, present - 0; 
Gait: > walks 5 m without aids -  12, walks with aids - 9, with help of another 
person - 6, without support - 3, bedridden/wheelchair - 0; 
Arm, motor power (assessed only on affected side):  raises arm with normal 
strength - 6, raises arm with reduced strength - 5, raises arm with flexion in elbow - 4, 
can move, but not against gravity - 2, paralysis - 0; 
Hand,  motor  power  (assessed  only  on  affected  side):  normal  strength  - 6, 
reduced strength in full range -  4, some movement, fingertips do not reach palm -  2, 
paralysis - 0; 
Leg, motor power (assessed only on affected side): normal strength - 6, raises 
straight leg with reduced strength - 5, raises leg with flexion of knee - 4, can move, but 
not against gravity - 2, paralysis - 0; 
Foot paresis: none - 2, present - 0. 
Serum cortisol
Serum cortisol is estimated by competitive immunoenzymatic calorimetric method 
(DiaMetra kit).  The analyzing laboratories were blinded to all clinical information about 
patients.
 Cortisol (antigen) in the sample competes with horseradish peroxidase-cortisol 
(enzyme labeled antigen) for binding on to the limited number of anti-cortisol (antibody) 
sites  on  the  microplates  (solid  phase).  After  incubation,  bound/free  separation  is 
performed by a simple solid phase washing. The enzyme substrate (H2O2) and the TMB-
substrate are added. After an appropriate time is elapsed for maximal color development, 
the enzyme reaction is stopped and absorbances are determined. Cortisol concentration in 
the sample is based on a series by a set of standard. The color intensity is inversely 
proportional to the cortisol concentration in the sample.
Statistical analysis
Statistical analysis was performed by SPSS 11.5 for Windows. Normal distribution 
was assessed by Kolmogorov Smirnov’s one-sample test. Spearman’s - correlation was 
applied in testing correlations in not continuous variables. Student’s  t  test was used in 
comparing  means  of  independent,  normally  distributed,  continuous  variables. 
Stratifications were based on the median of SSS score. Univariate logistic regression 
analysis and variables reaching a significance level of 0.1 in univariate analysis were 
done. 
A significance level of 0.05 was selected for the final model. Stroke severity as 
assessed by SSS and blood glucose,  body temperature,  pulse  rate,  total  WBC count, 
systolic  and diastolic  blood pressure   were correlated with serum cortisol.  Statistical 
significance were taken when the P value is < 0.05 (95% confidence interval)
OBSERVATIONS
Table No. 1
Patient characteristics
Patient characteristics
N=47 Percentage or Median with 
quartiles
Age
Male sex
H/o Hypertension
H/o Diabetes
H/o CAD
H/o Alcoholism
60 yrs (50-65)
55.3 %
42.6%
27.7%
14.9%
25.0%
Table No.2
Patient profile on admission
Patient indicators Mean Standard deviation
SBP 158.21 15.59
DBP 93.45 11.00
Pulse rate 85.45 8.35
Temperature 99.6 1.21
Total count 8348 1873.4
Blood sugar 103.36 21.29
Serum cortisol 33.52 11.20
SSS 27.55 8.56
Table No.3
Levels of correlation with SSS
Factor Correlation coefficient Significance P value
SBP -0.166 0.266
DBP -0.108 0.469
Pulse -0.057 0.703
Temperature -0.292 0.046
TC -0.161 0.279
Blood sugar -0.171 0.251
Serum cortisol -0.437 0.002
Table No.4
Levels of correlation with Serum cortisol
Factor Correlation coefficient Significance P value
SBP 0.282 0.055
DBP 0.167 0.262
Pulse 0.423 0.003
Temperature 0.312 0.001
TC 0.248 0.032
Blood sugar 0.248 0.093
SSS -0.437 0.002
                
Data from 47 patients participated in this study is finally entertained for analysis of 
which 26 patients are males (55.3%). The mean age of presentation is 58.21 yrs as shown 
in Table 1.
The  mean  duration  of  presentation  i.e.  from the  time  of  onset  of  stroke  and 
presentation to the hospital is 13.62 hours. Of the 47 patients enrolled for the study, 13 
persons  were  known  diabetics  (27.7%)  and  20  persons  were  known  hypertensives 
(42.6%).
Of  the  47  patients  enrolled  for  the  study,  8  (17%)  patients  were  having 
hemorrhagic stroke and the remaining were suffering from ischemic strokes. The most 
common  site  for  ischemic  stroke  was  MCA  territory  including  its  lenticulostriate 
branches.
Of  the  47  patients,  12  persons  (25.5%)  were  alcoholics  and  17  persons  were 
smokers (36.2%). Alcoholism and smoking were exclusively seen in males.
On admission, almost all the patients were having systolic blood pressure more 
than 140 mmHg. 29 patients (61.7%) were having diastolic blood pressure more than 90 
mmHg. The average temperature is about 99.6 degree F and the mean pulse rate is about 
85.45. 
The  investigations  showed total  WBC count  of  about  8400 cells/cu.mm as  an 
average. Blood sugar estimation revealed an average blood sugar of 103.36 mg/dL. 
Serum cortisol measured as the time of admission showed a mean of about 33.52 
mg/dL and a standard deviation of about 11.20 mg/dL. The value varied between 11.6 to 
52.8 mg/dL.
The Scandinavian stroke scale assessment at the time of admission ranged from 7 
to 41 in our patients for a total of 60. The mean SSS score is about 27.55 with standard 
deviation is about 8.56. 
The correlation between SSS and serum cortisol were analyzed. The correlation 
coefficient (rho ) is about -0.437 with a P value of 0.002.
The relationship between SSS score and other parameters were also analyzed. The 
correlation coefficient was more for body temperature (-0.292) with a P value of 0.045. 
The  correlation  coefficients  for  other  parameters  were  depicted  in  Table  3  with 
corresponding P values
To  analyse  the  relationship  of  serum  cortisol  and  the  important  parameters 
correlation  coefficients  were  computed.  The  highest  magnitude  of  correlation  was 
obtained for SSS score as depicted above. There is also good correlation between serum 
cortisol and body temperature. The other parameters are depicted in Table 4. 
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Fig.7 Correlation between SSS and Blood sugar
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Fig.8 Correlation between SSS and Total count
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Fig.9 Correlation between Systolic blood pressure and SSS
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Fig.10 Correlation between Diastolic blood pressure and SSS
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DISCUSSION
In this  study on Indian population involving 47 patients with stroke,  we 
evaluated the relationship between serum cortisol level and stroke severity as assessed by 
Scandinavian stroke scale score. This study shows a statistically significant correlation 
between serum cortisol and stroke severity (P<0.05).
Earlier  studies  have  shown  that  elevated  serum  cortisol  is  an  indirect 
indicator  of  stroke  severity.  This  is  evident  from our  study  that  showed  an  inverse 
correlation between SSS scores  which is  inversely related to  the stroke  severity  and 
increasing serum cortisol. 
We also tried to show correlation between serum cortisol and other clinical 
and paraclinical parameters of relevance in stroke. The most significant correlation is 
between serum cortisol and temperature (P=0.001). There is also statistically significant 
correlation  between  serum cortisol  with  total  WBC  count  (P=0.032)  and  pulse  rate 
(P=0.003)   
Eventhough earlier studies showed that blood glucose is related significantly 
to stoke severity and serum cortisol, in our study there is no significant correlation.
Although  there  is  a  direct  correlation  between  stroke  severity  and  both 
systolic and diastolic blood pressure, statistical significance was not obtained (P= 0.266 
and 0.469 respectively).
The limitation in our study is that ACTH, nor-adrenaline and adrenaline and 
other hormones involved in the stress response is not measured.
 
CONCLUSION
The following conclusions were derived from our study
1) High serum cortisol correlated with severity of stroke
2) High serum cortisol also correlated with pulse rate,  body temperature and WBC 
count.
SCOPE OF FUTURE STUDIES
This study conducted in Indian population has significant observations and 
potential  therapeutic  implications.  Still  few  questions  remain  unanswered.  Although 
serum cortisol  has  been convincingly  proved an independent  indicator  of  severity  of 
stroke, the exact pathophysiological mechanism of relationship has to be elucidated by 
further studies.
Estimation  of  other  harmones  involved  in  stress  response  such  as  ACTH, 
epinephrine, cytokines can be undertaken to correlate the severity of stroke.
Serum cortisol and stroke severity 
Proforma
Name: Age&Sex: IP No.
Time duration: Presenting complaints:
LOC: Seizures: Fever: Others:
History
HTN DM PT BA IHD
CVA Seizures Smoking Alcoholism
General Examination
GCS: BP: PR: JVP: Temperature:
Cranial nerves:  VII
CNS examination
SSS:
1. Consciousness
2. Orientation
3. Speech
4. Eye movements
5. Facial palsy
6. Gait
7. Arm power
8. Hand power
9. Leg power
10. Foot paresis
Investigations:
Blood Hb: TC: DC: ESR:
Blood Sugar: Urea: Creatinine: Electrolytes:
Lipid profile:
Serum cortisol:
USG abdomen:
ECG:
ECHO:
CT Brain:
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